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The state programme giving free antiretrovirals 
(ARVs) started on 1 April 2004 in several large 
centres across South Africa. For many of us, it 
seemed unimaginable, after years of running 
HIV battles with President Thabo Mbeki and 
his odious Minister of Health, ‘Manto’ Tshabalala-Msimang, on 
everything from the cause of HIV to the efficacy of ARVs. A 
decade later, the state programme is the biggest in the world, with 
millions of lives saved and families returned back to normal life.
I was involved in the initial design of the programme, and 
have since been heavily involved in the implementation in rural 
and urban environments. I like to think about what I’ve learnt 
about HIV, and all the things I got wrong. Interestingly, seeing 
where we are in 2014, much of what has happened in the last 
decade was as unimaginable as the heady days of starting all 
those sick, desperate people on ARVs in 2004.
Be ambitious
I remember Mark Heywood, the human rights crusader for 
Section 27, insisting that we put ‘80% antiretroviral coverage’ 
when we wrote the 2nd National Strategic Plan, released at the end 
of 2006. The fractious paediatricians also insisted on ambitious 
prevention of mother-to-child transmission (PMTCT) targets. 
At the time, there were few places with >30% ARV coverage, and 
reports of poor antenatal PMTCT coverage were everywhere. I 
thought that they were being silly. By 2010, ARV coverage was 
close to 80%, and PMTCT transmission rates had fallen below 2%. 
Even when we designed the programme, in 2002 in dark rooms 
in the Birchwood Hotel, we continually asked whether drugs 
were affordable. Before we knew it, we had a pretty good first 
and second line, which were refined in 2010. Now we sit with a 
world-class fixed-dose combination and third-line drugs not even 
available in many developed countries, thanks to the decrease in 
cost. The Minister’s crazy rush of blood to the head, where he 
wanted to test 20 million South Africans for HIV in one year in 
2010, maybe took a few months longer than he had anticipated, 
but it got there – even though I thought it was impossible – and 
we’re probably now the most tested nation on earth.
We’ve taught chronic diseases a thing 
or two about adherence
I come from the typical physician world of diabetes, hypertension 
and asthma, where we hug patients who get >70% adherence. 
The 90%-plus adherence demanded by ARVs seemed fanciful, 
until we tried it. Thanks to Médecins Sans Frontières (MSF) and 
the Treatment Action Campaign (TAC) and their adherence 
programmes, I’ve realised that meaningfully involving people 
in their care and making them understand their disease and 
how their drugs work, magically transforms them into prize 
adherence patients. I heard Prof. Steve Reid, a rural advocate, 
once say that he was amazed at how HIV patients could describe 
the lifecycle of the virus and evolution of resistance, while 
diabetic and hypertension patients, when asked what was wrong, 
would shrug and say: ‘I have the high-high’. 
We may have saved the world from TB 
If it wasn’t for the HIV world seizing the tuberculosis (TB) 
research and policy agenda, we’d still be stuck with the gross 
lack of ambition that has left us with third-rate TB drugs and 
tenth-rate TB diagnostics for decades, couched in one of the 
most offensive and patronising public health programmes of all 
– ‘DOTS’ – while staring down the barrel of a growing multidrug 
resistance (MDR) nightmare. It staggered me that my patients in 
Hillbrow could permanently take ARVs 90% of the time, but the 
same patients had a <50% completion rate of six months of TB 
therapy at the TB clinic across the road. The story of how they 
came to the recommended dose of rifampicin (essentially ‘what 
dose can we afford’), and my realisation that, far from what I was 
taught at med school, MDR was the fault of the programme (bad 
doses, poor support, poor understanding of the epidemiology), 
speaks volumes about the kind of history that TB has. It’s become 
better. I still think the programme lacks some creativity and 
certainly resources, but at least we have a fighting chance, thanks 
to the increasing focus by clinicians and activists and their 
demand for integrated therapy and better drugs and diagnostics.
We may have saved the world from  
old-fashioned public health specialists
Speaking of a lack of ambition, some of the most dispiriting conver-
sations I have had have been with conventional public health 
specialists, saying that we were diverting resources from their 
sanitation/food/whatever programmes, with our ‘non-sustainable’ 
HIV programmes. Initially, I was defensive, until I realised how 
they had failed our continent on so many levels for decades – 
whether health promotion or disease prevention. HIV is common, 















it mattered. ARVs alone have increased life expectancy in South Africa by 
a decade, in just a few years, making it one of the most powerful public 
health interventions ever, right up there with good sanitation and vaccines. 
HIV care has driven energy and creativity into health delivery, and the 
focus on an evidence base has, at least somewhat, allowed us to question 
some of the holy cows of public health – from the design of healthcare 
delivery, the evidence for cancer screening, to obesity definitions and food 
recommendations – and this has meant a new and critical generation of 
people who can claim to have public health expertise. Now we routinely 
demand attention to evidence bases, human rights and patient demands 
from public health programmes, not always successfully it must be said, but 
a far cry from the kind of largely irrelevant public health I grew up studying.
Health system inertia may be 
our biggest challenge
We sit with a health delivery system largely designed by European colonisers. 
They’ve moved on, but we have clung to a clinic-hospital, nurse-doctor 
model that was out of date 50 years ago. It is especially poor in dealing with 
an enlightened, google-empowered population asking hard questions of 
ill-prepared clinical services. Drug-delivery systems and training of health 
professionals seem constantly to be hamstrung by laws and rules generated 
by opaque bureaucracies within structures like the Health Professions 
Council of South Africa (HPCSA) and the Nursing Council – where it is 
very difficult to see which interest these structures serve. It seems we need 
massive re-engineering of the health system that goes well beyond what 
even the idealised National Health Insurance (NHI) looks like.
Attend many meetings and be patient
One of my epiphanies of the last 15 years of working with the Department 
of Health (DoH) (it’s true also in academia) is s/he who goes to the most 
meetings, wins. This is frustrating, but attention to process and keeping 
a beady eye on policy and choices, in an excitable field like HIV where 
there are many strident and powerful voices, is imperative. You can’t rely 
on minutes and proxies; you’ve just got to make sure that you get on that 
Gautrain to Civicus Building with a fully charged iPad and lots of coffee.
We need a strong civil society more than ever
For a while, we were all big buddies in the Zuma era. Government em-
braced activists and clinician groups. Post Manto, it was a breath of fresh 
air to be told how important we were. But we need to be careful – the 
defensiveness from prominent DoH members that followed the release 
of the drug stock-outs reported in December, including death threats 
and thuggish behaviour by security forces focused on TAC members in 
the Free State where the stock-outs were the worst, remind us of how 
prickly and unaccountable politicians and civil servants can be. We still 
do not have adequate explanation or closure on the bizarre Tara clamp 
issue, where a harmful device was used in the circumcision programmes 
in KwaZulu-Natal (KZN). Neliswa ‘Peggy’ Nkonyeni, ex-health minister 
for KZN, instrumental in several superb KZN healthcare workers losing 
their jobs when she was Manto’s quack foot soldier, is making a political 
comeback, and there are many people from Mbeki’s cabinet who still 
seem to be successful, despite sitting quietly in his AIDS-denialist circle 
(c’mon Trevor, what really happened?). At a provincial level, patient 
advocates and concerned clinicians are routinely treated as optional 
extras or have their jobs threatened if they rock the boat in local AIDS 
councils. ‘Protection’ agencies such as the HPCSA continue to let Wouter 
Basson earn a handsome living while his victims’ families live in poverty, 
while slapping down non-governmental organisations (NGOs) who 
support whistle-blowing with spurious appeals to privacy; the HPCSA 
and Nursing Council seem to think that it’s better to let rural people die 
for want of healthcare, than license foreigners willing to work in places 
desperate for their skills. Civil society needs your money and your 
support, for all our future, to take on powerful vested interests.
The private sector, unions, churches 
and educational institutions have had 
a largely easy ride
The excesses of the Mbeki era have allowed for many of these sectors 
to coast quietly on World AIDS Day platitudes and occasional HIV 
testing campaigns. I’m struck at Dr Jan Pienaar’s aggressive no-
nonsense HIV programme tackling new infections, stigma and fear at 
Anglo-American’s Thermal Coal, and at the empty public statements 
from banks, shopping chains, universities, unions, major churches (in 
fairness, I’ve seen some amazing courage, especially from some Catholic 
groups), large NGOs, and opposition political parties. We need tangible 
commitments to testing and treating people, not the candle-lighting 
hand-wringing we all dread every 1 December.
I visited a very rural hospital in the Eastern Cape in late December – 
simply tarring the disastrous dirt road, now promised for years, would 
make ambulances accessible, health staff happier and prepared to stay, 
and allow for better support. The staff accommodation is appalling, and 
the hospital perennially grapples with understaffing. Not a single South 
African doctor works there. I was angry at how a middle-income country 
could let its citizens be neglected in this way. But the senior doctor 
working there spoke approvingly of the new district manager and how he 
was trying to get things going, about how she had got cooperation from 
the nurses by improving their living conditions, how the doctors were 
happier, and how successful the ARV programme was. We picked up a 
rural woman looking for a lift en route to the hospital, who spoke loudly 
and confidently about how she loved ‘our hospital’ (it was embarrassing 
that the doctor, who is from Europe, had to translate for me). A week 
later, back in civilisation, I bumped into a newly appointed senior 
member of the DoH who I’ve known and respected for years, who knew 
all the details of the hospital and the district manager, and rattled off 
ambitious plans for the next six months, expressing deep dismay at the 
previous maladministration. There is cause for hope.
We all have a stake in our DoH being as strong as it can be. There is 
a lot to be angry and concerned about, but it can’t stop there. We have 
to continue to work constructively and critically, even if we are told 
we are not welcome at times. We need the protective institutions to be 
challenged, and we need to continue to strengthen civil society, even if 
it is just giving them much-needed cash. We need to keep re-imagining 
a better healthcare system. And we need to attend those long meetings.
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‘ ... he was amazed at how HIV 
patients could describe the 
lifecycle of the virus and evolution 
of resistance, while diabetic and 
hypertension patients, when asked 
what was wrong, would shrug and 
say: "I have the high-high". ’  
